Annual Current Liabilities
$18.88 M
+$704.00 K+3.87%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual total current liabilities is currently $18.88 million, with the most recent change of +$704.00 thousand (+3.87%) on 31 December 2023. During the last 3 years, it has risen by +$9.06 million (+92.32%). TNXP annual current liabilities is now -13.04% below its all-time high of $21.72 million, reached on 31 December 2021.TNXP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$15.18 M
-$6.86 M-31.13%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly total current liabilities is currently $15.18 million, with the most recent change of -$6.86 million (-31.13%) on 30 September 2024. Over the past year, it has dropped by -$2.55 million (-14.39%). TNXP quarterly current liabilities is now -31.13% below its all-time high of $22.04 million, reached on 30 June 2024.TNXP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | -14.4% |
| 3 y3 years | +92.3% | +26.2% |
| 5 y5 years | +611.3% | +541.6% |
TNXP Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.0% | +92.3% | -31.1% | +26.2% |
| 5 y | 5 years | -13.0% | +611.3% | -31.1% | +541.6% |
| alltime | all time | -13.0% | >+9999.0% | -31.1% |
Tonix Pharmaceuticals Holding Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.18 M(-31.1%) |
| June 2024 | - | $22.04 M(+7.6%) |
| Mar 2024 | - | $20.48 M(+8.4%) |
| Dec 2023 | $18.88 M(+3.9%) | $18.88 M(+6.5%) |
| Sept 2023 | - | $17.73 M(-3.8%) |
| June 2023 | - | $18.44 M(+41.1%) |
| Mar 2023 | - | $13.07 M(-28.1%) |
| Dec 2022 | $18.18 M(-16.3%) | $18.18 M(+36.3%) |
| Sept 2022 | - | $13.34 M(-16.1%) |
| June 2022 | - | $15.91 M(+3.6%) |
| Mar 2022 | - | $15.35 M(-29.3%) |
| Dec 2021 | $21.72 M(+121.2%) | $21.72 M(+80.6%) |
| Sept 2021 | - | $12.03 M(+48.8%) |
| June 2021 | - | $8.08 M(+34.1%) |
| Mar 2021 | - | $6.03 M(-38.6%) |
| Dec 2020 | $9.82 M(+91.2%) | $9.82 M(+124.3%) |
| Sept 2020 | - | $4.38 M(-6.4%) |
| June 2020 | - | $4.68 M(+75.9%) |
| Mar 2020 | - | $2.66 M(-48.2%) |
| Dec 2019 | $5.13 M(+93.4%) | $5.13 M(+117.0%) |
| Sept 2019 | - | $2.37 M(+15.6%) |
| June 2019 | - | $2.05 M(+1.8%) |
| Mar 2019 | - | $2.01 M(-24.3%) |
| Dec 2018 | $2.65 M(+24.9%) | $2.65 M(+13.2%) |
| Sept 2018 | - | $2.35 M(-6.6%) |
| June 2018 | - | $2.51 M(+6.3%) |
| Mar 2018 | - | $2.36 M(+11.2%) |
| Dec 2017 | $2.13 M(+0.5%) | $2.13 M(+15.7%) |
| Sept 2017 | - | $1.84 M(+0.4%) |
| June 2017 | - | $1.83 M(+2.8%) |
| Mar 2017 | - | $1.78 M(-15.9%) |
| Dec 2016 | $2.12 M | $2.12 M(-19.2%) |
| Sept 2016 | - | $2.62 M(-37.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $4.20 M(+7.3%) |
| Mar 2016 | - | $3.91 M(-41.2%) |
| Dec 2015 | $6.65 M(+96.6%) | $6.65 M(+30.5%) |
| Sept 2015 | - | $5.10 M(+10.3%) |
| June 2015 | - | $4.62 M(+31.3%) |
| Mar 2015 | - | $3.52 M(+4.0%) |
| Dec 2014 | $3.38 M(+53.0%) | $3.38 M(-3.3%) |
| Sept 2014 | - | $3.50 M(+47.5%) |
| June 2014 | - | $2.37 M(+4.2%) |
| Mar 2014 | - | $2.27 M(+2.9%) |
| Dec 2013 | $2.21 M(+94.3%) | $2.21 M(+4.3%) |
| Sept 2013 | - | $2.12 M(-6.3%) |
| June 2013 | - | $2.26 M(+86.0%) |
| Mar 2013 | - | $1.22 M(+6.9%) |
| Dec 2012 | $1.14 M(+23.0%) | $1.14 M(+36.0%) |
| Sept 2012 | - | $836.80 K(+6.9%) |
| June 2012 | - | $782.80 K(+175.3%) |
| Mar 2012 | - | $284.30 K(-69.3%) |
| Dec 2011 | $925.30 K(+171.9%) | $925.30 K(+5987.5%) |
| Sept 2011 | - | $15.20 K(+12.6%) |
| June 2011 | - | $13.50 K(+7.1%) |
| Mar 2011 | - | $12.60 K(-96.3%) |
| Dec 2010 | $340.30 K(>+9900.0%) | $340.30 K(+8625.6%) |
| Sept 2010 | - | $3900.00(+1200.0%) |
| June 2010 | - | $300.00(0.0%) |
| Mar 2010 | - | $300.00(-70.0%) |
| Dec 2009 | $1000.00(-66.7%) | $1000.00(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(-100.0%) |
| Dec 2008 | $3000.00 | $3000.00(-93.0%) |
| Sept 2008 | - | $43.00 K(+93.7%) |
| June 2008 | - | $22.20 K(>+9900.0%) |
| Mar 2008 | - | $0.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual total current liabilities?
- What is the all time high annual current liabilities for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual current liabilities year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly current liabilities year-on-year change?
What is Tonix Pharmaceuticals Holding annual total current liabilities?
The current annual current liabilities of TNXP is $18.88 M
What is the all time high annual current liabilities for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual total current liabilities is $21.72 M
What is Tonix Pharmaceuticals Holding annual current liabilities year-on-year change?
Over the past year, TNXP annual total current liabilities has changed by +$704.00 K (+3.87%)
What is Tonix Pharmaceuticals Holding quarterly total current liabilities?
The current quarterly current liabilities of TNXP is $15.18 M
What is the all time high quarterly current liabilities for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly total current liabilities is $22.04 M
What is Tonix Pharmaceuticals Holding quarterly current liabilities year-on-year change?
Over the past year, TNXP quarterly total current liabilities has changed by -$2.55 M (-14.39%)